RedHill Biopharma (RDHL) EBIT Margin (2012 - 2023)
RedHill Biopharma (RDHL) posted quarterly EBIT Margin of 2992.87% for Q2 2023, up 294295.0% year-over-year from N/an in Q2 2022, and up 470.4% quarter-over-quarter from 808.0% in Q1 2023.
RedHill Biopharma (RDHL) EBIT Margin (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported EBIT Margin for 12 consecutive years, with 2992.87% the latest figure, recorded in Q2 2023.
- In Q2 2023, EBIT Margin rose 294295.0% year-over-year to 2992.87%; the TTM figure through Jun 2023 stood at 122.98% (up 797.0% YoY), while the FY2025 annual figure was 2776.92%, down 269642.0% from the prior year.
- EBIT Margin climbed to 2992.87% in Q2 2023 per RDHL's latest filing, from 808.0% in the prior quarter.
- Across five years, EBIT Margin topped out at 2992.87% in Q2 2023 and bottomed at 808.0% in Q1 2023.
- Historically, EBIT Margin has averaged 336.14% across 5 years, with a median of 90.03% in 2020.
- Annual changes were most pronounced in 2021 — EBIT Margin sank 152314 bps — and 2023, when it jumped 294295 bps.
- RedHill Biopharma's EBIT Margin stood at 739.87% in 2019, then sank by 88 bps to 91.83% in 2020, then slumped by 798 bps to 641.43% in 2021, then climbed by 8 bps to 591.81% in 2022, then jumped by 606 bps to 2992.87% in 2023.
- Business Quant data shows RDHL's EBIT Margin at 2992.87% in Q2 2023, 808.0% in Q1 2023, and 591.81% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 2,992.87% |
| Mar 31, 2023 | -808.00% |
| Dec 31, 2022 | -591.81% |
| Sep 30, 2022 | 40.50% |
| Jun 30, 2022 | 49.92% |
| Mar 31, 2022 | 126.90% |
| Dec 31, 2021 | -641.43% |
| Sep 30, 2021 | 80.51% |
| Jun 30, 2021 | 115.74% |
| Mar 31, 2021 | 88.22% |
| Dec 31, 2020 | 91.83% |
| Sep 30, 2020 | 69.04% |
| Jun 30, 2020 | 59.81% |
| Mar 31, 2020 | 1,611.36% |
| Dec 31, 2019 | 739.87% |
| Sep 30, 2019 | 702.64% |
| Jun 30, 2019 | 792.07% |
| Mar 31, 2019 | 530.40% |
| Dec 31, 2018 | 739.00% |
| Sep 30, 2018 | 441.34% |